Cargando…

The molecular basis for the neutral effect of renal denervation in patients with chronic heart failure not responding to cardiac resynchronisation therapy – a perspective

Detalles Bibliográficos
Autores principales:	Kiuchi, Márcio Galindo, Carnagarin, Revathy, Matthews, Vance Bruce, Schlaich, Markus P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Termedia Publishing House 2019
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6956452/ https://www.ncbi.nlm.nih.gov/pubmed/31933672 http://dx.doi.org/10.5114/aic.2019.90231

Ejemplares similares

Multi-organ denervation: a novel approach to combat cardiometabolic disease
por: Kiuchi, Márcio Galindo, et al.
Publicado: (2023)

Renal denervation as a synergistic tool for the treatment of polymorphic ventricular ectopic beats: A case report
por: Kiuchi, Márcio Galindo, et al.
Publicado: (2020)

Relevance of Targeting the Distal Renal Artery and Branches with Radiofrequency Renal Denervation Approaches—A Secondary Analysis from a Hypertensive CKD Patient Cohort
por: Kiuchi, Márcio Galindo, et al.
Publicado: (2019)

Combined renal and common hepatic artery denervation as a novel approach to reduce cardiometabolic risk: technical approach, feasibility and safety in a pre-clinical model
por: Kiuchi, Márcio Galindo, et al.
Publicado: (2021)

Sympathetic Nervous System Activation and Its Modulation: Role in Atrial Fibrillation
por: Carnagarin, Revathy, et al.
Publicado: (2019)

Sympathetic Activation in Hypertensive Chronic Kidney Disease – A Stimulus for Cardiac Arrhythmias and Sudden Cardiac Death?
por: Kiuchi, Márcio Galindo, et al.
Publicado: (2020)

New Approaches in the Management of Sudden Cardiac Death in Patients with Heart Failure—Targeting the Sympathetic Nervous System
por: Kiuchi, Márcio Galindo, et al.
Publicado: (2019)

Renal denervation: back on track
por: Kiuchi, Márcio Galindo
Publicado: (2018)

Focusing on Sodium Glucose Cotransporter-2 and the Sympathetic Nervous System: Potential Impact in Diabetic Retinopathy
por: Herat, Lakshini Y., et al.
Publicado: (2018)

The Schlager mouse as a model of altered retinal phenotype
por: Herat, Lakshini Y., et al.
Publicado: (2019)

Machine learning powered tools for automated analysis of muscle sympathetic nerve activity recordings
por: Nolde, Janis M., et al.
Publicado: (2021)

Current Knowledge of IL-6 Cytokine Family Members in Acute and Chronic Kidney Disease
por: Magno, Aaron L., et al.
Publicado: (2019)

Supine blood pressure—A clinically relevant determinant of vascular target organ damage in hypertensive patients
por: Nolde, Janis M., et al.
Publicado: (2020)

Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)—A Condition Associated with Heightened Sympathetic Activation
por: Carnagarin, Revathy, et al.
Publicado: (2021)

SGLT2 Inhibitor–Induced Sympathoinhibition: A Novel Mechanism for Cardiorenal Protection
por: Herat, Lakshini Y., et al.
Publicado: (2020)

Effectiveness of renal sympathetic denervation in renal function and blood pressure in CKD and non-CKD patients with controlled vs. uncontrolled hypertension
por: Kiuchi, Márcio Galindo, et al.
Publicado: (2016)

Case Report: Renal Sympathetic Denervation as a Tool for the Treatment of Refractory Inappropriate Sinus Tachycardia
por: Kiuchi, Márcio Galindo, et al.
Publicado: (2015)

Microvascular changes at different stages of chronic kidney disease
por: Kannenkeril, Dennis, et al.
Publicado: (2020)

Renal sympathetic denervation guided by renal nerve stimulation to treat ventricular arrhythmia in CKD patients with ICD
por: Kiuchi, Márcio Galindo, et al.
Publicado: (2017)

Improving Cardiac Resynchronisation Therapy
por: Thomas, George, et al.
Publicado: (2019)

Age of cardiac resynchronisation therapy; cardiac resynchronisation therapy in elderly
por: Cerit, Levent
Publicado: (2016)

Circulating platelet‐derived extracellular vesicles correlate with night‐time blood pressure and vascular organ damage and may represent an integrative biomarker of vascular health
por: Lugo‐Gavidia, Leslie Marisol, et al.
Publicado: (2022)

Association of Circulating Platelet Extracellular Vesicles and Pulse Wave Velocity with Cardiovascular Risk Estimation
por: Lugo-Gavidia, Leslie Marisol, et al.
Publicado: (2022)

Cardiac resynchronisation improves survival in mild heart failure!
por: van der Wall, E. E.
Publicado: (2011)

Homocysteine predicts vascular target organ damage in hypertension and may serve as guidance for first‐line antihypertensive therapy
por: Carnagarin, Revathy, et al.
Publicado: (2021)

Is Cardiac Resynchronisation Therapy Proarrhythmic?
por: Leyva, Francisco, et al.
Publicado: (2008)

Gender in cardiac resynchronisation therapy
por: Enina, Tatiana N., et al.
Publicado: (2018)

A Case Report of Renal Sympathetic Denervation for the Treatment of Polymorphic Ventricular Premature Complexes: Expanding Horizons
por: Kiuchi, Márcio Galindo, et al.
Publicado: (2015)

Retinal capillary rarefaction is associated with arterial and kidney damage in hypertension
por: Frost, Shaun, et al.
Publicado: (2021)

Current aspects of cardiac resynchronisation therapy
por: Meine, M., et al.
Publicado: (2015)

Cardiac resynchronisation therapy in optima forma
por: Timmer, S. A. J., et al.
Publicado: (2022)

Cardiac resynchronisation therapy in optima forma
por: Timmer, S. A. J., et al.
Publicado: (2022)

Conduction System Pacing for Cardiac Resynchronisation
por: Sharma, Parikshit S, et al.
Publicado: (2021)

Cardiac Resynchronisation with Conduction System Pacing
por: Ezzeddine, Fatima M, et al.
Publicado: (2023)

Managing arrhythmia in cardiac resynchronisation therapy
por: de Vere, Felicity, et al.
Publicado: (2023)

Progress in Cardiac Resynchronisation Therapy and Optimisation
por: Akhtar, Zaki, et al.
Publicado: (2023)

The Influence of Hypertensive Therapies on Circulating Factors: Clinical Implications for SCFAs, FGF21, TNFSF14 and TNF-α
por: Magno, Aaron L., et al.
Publicado: (2020)

Haemodynamic evaluation of alternative left ventricular endocardial pacing sites in clinical non-responders to cardiac resynchronisation therapy
por: van Gelder, B.M., et al.
Publicado: (2015)

Reconsidering Renal Sympathetic Denervation for Heart Failure
por: Tang, W.H. Wilson, et al.
Publicado: (2017)

Comparison of Long‐Term Outcomes for Responders Versus Non‐Responders Following Renal Denervation in Resistant Hypertension
por: Fengler, Karl, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_h247evd6fmrm6ps1jbfs9l6m3m